stars 1 stars 2 stars 3

Sweet vaccines are novel carbohydrate based vaccines being developed by the company Malcisbo. The first targets are unmet medical needs such as Campylobacter induced food poisoning and parasitic infections by the blood sucking stomach worm Hemonchus in sheep causing losses in food production. Malcisbo has developed a proprietary target discovery platform which it will use in combination with glycoengineering technologies to provide novel and efficient glycoconjugate vaccines. The discovery platform will generate a constant outflow of novel vaccines for unmet human and veterinary medical needs. Further projects are affordable vaccines to protect people in underdeveloped areas against parasitic worm infections.

Malcisbo Ltd. Questions

The Malcisbo Ltd. annual revenue was $5 million in 2026.

Lino Camponovo is the CEO of Malcisbo Ltd..

1 people are employed at Malcisbo Ltd..

Malcisbo Ltd. is based in Schlieren, Zurich.

The NAICS codes for Malcisbo Ltd. are [32541, 3254, 325, 325414, 32].

The SIC codes for Malcisbo Ltd. are [283, 28].

Top Malcisbo Ltd. Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users